Office-Based Spirometry: A New Model of Care in Preoperative Assessment for Low- Risk Lung Resections Jessica L. Hudson, MD, MPHS, Jennifer M. Bell, BSN,

Slides:

Advertisements

Similar presentations

Daniel C. Thomas, MD, MPH, Brian N. Arnold, MD, Jessica R

Advertisements

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Evaluation of the Reliability of Clinical Staging of T2 N0 Esophageal Cancer: A Review of The Society of Thoracic Surgeons Database Traves D. Crabtree,

Endoscopic Ultrasound for Early Stage Esophageal Adenocarcinoma: Implications for Staging and Survival Traves D. Crabtree, MD, Wael N. Yacoub, MD, Varun.

Usefulness of Lung Perfusion Scintigraphy Before Lung Cancer Resection in Patients with Ventilatory Obstruction Tommaso C. Mineo, MD, Orazio Schillaci,

Does the method of radiologic surveillance affect survival after resection of stage I non– small cell lung cancer? Traves D. Crabtree, MD, Varun Puri,

Trevor Williams, MD, MPH, Brian C

Thoracic Epidural Versus Intercostal Nerve Catheter Plus Patient-Controlled Analgesia: A Randomized Study James D. Luketich, MD, Stephanie R. Land, PhD,

Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation Don Hayes, MD, MS, Stephen Kirkby,

Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M

Diaphragmatic Defect Complicating Peritoneal Dialysis

Prognostic Factors Associated With Interventional Bronchoscopy in Lung Cancer Nicolas Guibert, MD, Julien Mazieres, MD, PhD, Benoît Lepage, MD, Gavin.

Does the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation? Cliff K. Choong, FRACS, Bryan.

The Benefits of Continuous and Digital Air Leak Assessment After Elective Pulmonary Resection: A Prospective Study Robert J. Cerfolio, MD, Ayesha S.

Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation Don Hayes, MD, MS, Sylvester M. Black,

Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy

Using Surgeon-Specific Outcome Reports and Positive Deviance for Continuous Quality Improvement Jelena Ivanovic, MS, PhD, Caitlin Anstee, BA, Tim Ramsay,

Mark F. Berry, MD, Nestor R. Villamizar-Ortiz, MD, Betty C

Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer Justin A. Drake, MD, David C. Portnoy, MD, Kurt.

National Patterns of Care and Outcomes After Combined Modality Therapy for Stage IIIA Non–Small-Cell Lung Cancer Aalok P. Patel, BS, Traves D. Crabtree,

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Therapeutic Bronchoscopy Interventions Before Surgical Resection of Lung Cancer Prashant N. Chhajed, MD, Ralf Eberhardt, MD, Hendrik Dienemann, MD, Andrea.

Katy A. Marino, MD, Jennifer L. Sullivan, MD, Benny Weksler, MD

Trevor Williams, MD, MPH, Brian C

Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer Usman Ahmad, MD, Traves D. Crabtree,

Defining the Ideal Time Interval Between Planned Induction Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer Pamela Samson, MD, MPHS, Traves.

The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness Analysis Pamela Samson, MD, Aalok Patel, BS,

Tara R. Semenkovich, MD, MPHS, Christine Frederiksen, MS, Jessica L

Effects of Extended Pleurectomy and Decortication on Quality of Life and Pulmonary Function in Patients With Malignant Pleural Mesothelioma David Burkholder,

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

The National Surgical Quality Improvement Program risk calculator does not adequately stratify risk for patients with clinical stage I non–small cell.

Transthoracic Repair of Slipped Nissen Fundoplications: Technique and Results Ruchir Puri, MD, Adam M. Cline, MD, MS, Daniel T. DeArmond, MD, Scott B.

Robert J. Moraca, MD, Marc R. Moon, MD, Jennifer S

Pulmonary Function Tests Overestimate Chronic Pulmonary Disease in Patients With Severe Aortic Stenosis Mitchell J. Magee, MD, Morley A. Herbert, PhD,

Use of Amiodarone After Major Lung Resection

Impact of Video-Assisted Thoracoscopic Surgery on Benign Resections for Solitary Pulmonary Nodules Elbert Kuo, MD, MPH, Ankit Bharat, MD, Nicholas Bontumasi,

Graduate Subspecialty and Perceptions of Cardiothoracic Surgery Training: A 60-Year Retrospective Study Mara B. Antonoff, MD, Jessica G.Y. Luc, MD, G.

Treatment Outcomes in Stage I Lung Cancer

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Lung Function and ECMO After Lung Transplantation

Dysphagia in the Young Male: The Ringed Esophagus

Extent of Lymphadenectomy Is Associated With Improved Overall Survival After Esophagectomy With or Without Induction Therapy Pamela Samson, MD, MPHS,

Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty

Mara B. Antonoff, MD, Varun Puri, MD, Bryan F

Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Mark F. Berry, MD, Chi-Fu Jeffrey.

Impact of induction chemoradiotherapy on pulmonary function after lobectomy for lung cancer Hiroaki Nomori, MD, Atsushi Shiraishi, MD, Yue Cong, MD,

Changes in Pulmonary Function in Lung Cancer Patients After Video-Assisted Thoracic Surgery Se Joong Kim, MD, PhD, Yeon Joo Lee, MD, Jong Sun Park, MD,

Daniel Kreisel, MD, PhD, Alexander S

Editorial Board, January 2010

Michael T. Durheim, MD, Sunghee Kim, PhD, Brian C

Single Versus Double Lung Retransplantation Does Not Affect Survival Based on Previous Transplant Type Erin M. Schumer, MD, MPH, Jonathan D. Rice, MD,

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

Stephen R. Broderick, MD, MPHS, Aalok P. Patel, BS, BA, Traves D

Predicted Versus Observed FEV1 and Dlco After Major Lung Resection: A Prospective Evaluation at Different Postoperative Periods Alessandro Brunelli,

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Patterns of care in hilar node-positive (N1) non–small cell lung cancer: A missed treatment opportunity? Matthew J. Bott, MD, Aalok P. Patel, BS, Vivek.

Lung Herniation After Supraclavicular Thoracic Outlet Decompression

Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer Pamela Samson, MD, Aalok Patel,

Digital Drainage System Reduces Hospitalization After Video-Assisted Thoracoscopic Surgery Lung Resection Daniel L. Miller, MD, Gerald A. Helms, MD,

Varun Puri, MD, Yinin Hu, MS, Tracey Guthrie, RN, Traves D

Yinin Hu, MD, Timothy L. McMurry, PhD, Kristen M. Wells, PhD, James M

Treatment of Malignant Pleural Effusion: A Cost-Effectiveness Analysis

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Spencer J. Melby, MD, Shane J. Larue, MD, John M

The Impact of New Technology on Cardiothoracic Surgical Practice

Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support Peter B. Manning, MD, Michael J. Rutter, MD,

Leukocytosis and Increased Risk of Atrial Fibrillation After General Thoracic Surgery David Amar, MD, Anuj Goenka, BS, Hao Zhang, MD, Bernard Park, MD,

Michelle C. Wallace, MD, James Jaggers, MD, Jennifer S

Presentation transcript:

Office-Based Spirometry: A New Model of Care in Preoperative Assessment for Low- Risk Lung Resections Jessica L. Hudson, MD, MPHS, Jennifer M. Bell, BSN, Traves D. Crabtree, MD, Daniel Kreisel, MD, PhD, G. Alexander Patterson, MD, Bryan F. Meyers, MD, MPH, Varun Puri, MD, MSCI The Annals of Thoracic Surgery Volume 105, Issue 1, Pages 279-286 (January 2018) DOI: 10.1016/j.athoracsur.2017.08.010 Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Inclusion schema and resultant pairs after propensity score matching. (FEV1 = forced expiratory volume in 1 second; LS = laboratory spirometry; OS = office spirometry; PFT = pulmonary function test; Preop = preoperative.) The Annals of Thoracic Surgery 2018 105, 279-286DOI: (10.1016/j.athoracsur.2017.08.010) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Distribution of propensity score (A) before and (B) after matching office spirometry and laboratory spirometry patients. Purple represents the propensity scores for office spirometry while orange represents the propensity scores of laboratory spirometry. The region of overlapping propensity scores is therefore displayed as pink. The Annals of Thoracic Surgery 2018 105, 279-286DOI: (10.1016/j.athoracsur.2017.08.010) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Standardized differences before and after propensity score matching for variables included in the propensity score logistic regression model. Blue dashed vertical lines represent the limits, ±10%, outside of which standardized differences indicate imbalance. (ASA = American Society of Anesthesiologists; FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity.) The Annals of Thoracic Surgery 2018 105, 279-286DOI: (10.1016/j.athoracsur.2017.08.010) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions